Comparison of the effects of losartan potassium and benazepril in the treatment of hypertensive patients with insulin resistance

To compare the efficacy of losartan potassium (LP) and benazepril in the treatment of hypertensive patients with insulin resistance (IR). This is a retrospective analysis of the clinical data of 155 hypertensive patients with IR admitted to Shanghai Pudong New Area People's Hospital from March...

Full description

Saved in:
Bibliographic Details
Published in:Pakistan journal of medical sciences 2024-09, Vol.40 (8), p.1608
Main Authors: Ma, Tingting, Wang, Yangui, Liu, Haixia, Wang, Tao, Zhao, Yue, Li, Yao
Format: Article
Language:English
Subjects:
Antihypertensives
Benazepril
Blood pressure
Care and treatment
Dextrose
Diabetes therapy
Glucose
Hypertension
Hypoglycemic agents
Insulin resistance
Losartan
Metabolic disorders
Normal distribution
Physiological aspects
Potassium
Smooth muscle
Sodium
Type 2 diabetes
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To compare the efficacy of losartan potassium (LP) and benazepril in the treatment of hypertensive patients with insulin resistance (IR). This is a retrospective analysis of the clinical data of 155 hypertensive patients with IR admitted to Shanghai Pudong New Area People's Hospital from March 2021 to March 2023. Of these 76 received LP treatment (LP group), and 79 received benazepril treatment (benazepril group). Blood pressure levels, blood glucose and insulin levels, treatment efficacy, and incidence of adverse reactions before and after the treatment in both groups were compared. After the treatment, diastolic and systolic blood pressure in the two groups significantly decreased compared to pre-treatment levels ( 0.05). After the treatment, levels of fasting plasma glucose (FPG), 2-hours plasma glucose (2hPG), fasting insulin (FINS), 2-hours insulin (2hINS), and insulin sensitivity index (ISI) in both groups significantly decreased compared to pre-treatment levels ( 0.05). There was no significant difference in the total efficacy and the incidence of adverse reactions between the two groups ( >0.05). The efficacy of LP and benazepril in treating hypertension with IR is equivalent. Both are safe and can effectively lower blood sugar and insulin levels, alleviate IR, and lower blood pressure.
ISSN:1682-024X
1681-715X
DOI:10.12669/pjms.40.8.9896